What is Healthstream's earnings per share (EPS)?

Healthstream (HSTM) reported diluted earnings per share of $0.61 for fiscal year 2025. This represents a -7.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Healthstream Financials

HSTM

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Healthstream (HSTM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 47/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Healthstream has an operating margin of 6.7%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 37/100, indicating healthy but not exceptional operating efficiency. This is down from 7.3% the prior year.

Growth

Healthstream's revenue grew a modest 4.3% year-over-year to $304.1M. This slow but positive growth earns a score of 40/100.

Leverage

Healthstream carries a low D/E ratio of 0.47, meaning only $0.47 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 92/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Healthstream's current ratio of 0.96 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 14/100, which could limit financial flexibility.

Cash Flow

Healthstream converts 19.6% of revenue into free cash flow ($59.6M). This strong cash generation earns a score of 74/100.

Returns

Healthstream generates a 5.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 23/100. This is down from 5.6% the prior year.

Altman Z-Score Safe

3.19

Healthstream scores 3.19, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($598.9M) relative to total liabilities ($166.4M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

5/9

Healthstream passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

3.45x

For every $1 of reported earnings, Healthstream generates $3.45 in operating cash flow ($63.3M OCF vs $18.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$304.1M

YoY+4.3%

5Y CAGR+4.4%

10Y CAGR+3.8%

Healthstream generated $304.1M in revenue in fiscal year 2025. This represents an increase of 4.3% from the prior year.

EBITDA

$63.7M

YoY+1.9%

5Y CAGR+6.7%

10Y CAGR+7.6%

Healthstream's EBITDA was $63.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 1.9% from the prior year.

Net Income

$18.3M

YoY-8.3%

5Y CAGR+5.4%

10Y CAGR+7.8%

Healthstream reported $18.3M in net income in fiscal year 2025. This represents a decrease of 8.3% from the prior year.

EPS (Diluted)

$0.61

YoY-7.6%

5Y CAGR+6.8%

10Y CAGR+8.1%

Healthstream earned $0.61 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 7.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$59.6M

YoY+6.0%

5Y CAGR+12.0%

10Y CAGR+8.3%

Healthstream generated $59.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 6.0% from the prior year.

Cash & Debt

$36.2M

YoY-39.2%

5Y CAGR-0.2%

10Y CAGR-7.9%

Healthstream held $36.2M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.12

YoY+10.7%

Healthstream paid $0.12 per share in dividends in fiscal year 2025. This represents an increase of 10.7% from the prior year.

Shares Outstanding

30M

YoY-2.8%

5Y CAGR-1.3%

10Y CAGR-0.7%

Healthstream had 30M shares outstanding in fiscal year 2025. This represents a decrease of 2.8% from the prior year.

Margins & Returns

Gross Margin

64.7%

YoY-1.7pp

5Y CAGR+1.2pp

Healthstream's gross margin was 64.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the prior year.

Operating Margin

6.7%

YoY-0.6pp

5Y CAGR+0.2pp

10Y CAGR+0.2pp

Healthstream's operating margin was 6.7% in fiscal year 2025, reflecting core business profitability. This is down 0.6 percentage points from the prior year.

Net Margin

6.0%

YoY-0.8pp

5Y CAGR+0.3pp

10Y CAGR+1.9pp

Healthstream's net profit margin was 6.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.8 percentage points from the prior year.

Return on Equity

5.2%

YoY-0.4pp

5Y CAGR+1.0pp

10Y CAGR+2.1pp

Healthstream's ROE was 5.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.4 percentage points from the prior year.

Capital Allocation

R&D Spending

$51.0M

YoY+4.3%

5Y CAGR+9.6%

10Y CAGR+7.7%

Healthstream invested $51.0M in research and development in fiscal year 2025. This represents an increase of 4.3% from the prior year.

Share Buybacks

$30.0M

5Y CAGR+8.4%

Healthstream spent $30.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$3.7M

YoY+163.0%

5Y CAGR+13.1%

10Y CAGR-7.6%

Healthstream invested $3.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 163.0% from the prior year.

HSTM Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$304.1M+4.3%	$291.6M+4.5%	$279.1M+4.6%	$266.8M+3.9%	$256.7M+4.9%	$244.8M
Cost of Revenue	$107.2M+9.5%	$97.9M+3.1%	$95.0M+4.3%	$91.1M+0.1%	$91.0M+1.9%	$89.3M
Gross Profit	$196.9M+1.6%	$193.7M+5.3%	$184.0M+4.8%	$175.7M+6.0%	$165.7M+6.6%	$155.5M
R&D Expenses	$51.0M+4.3%	$48.9M+7.4%	$45.5M+2.9%	$44.3M+6.3%	$41.7M+29.0%	$32.3M
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	$20.2M-4.9%	$21.3M+32.9%	$16.0M+28.7%	$12.4M+54.5%	$8.1M-49.1%	$15.8M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$4.9M+1.7%	$4.8M+45.4%	$3.3M-5.6%	$3.5M+81.9%	$1.9M-48.5%	$3.7M
Net Income	$18.3M-8.3%	$20.0M+31.5%	$15.2M+25.8%	$12.1M+106.9%	$5.8M-58.5%	$14.1M
EPS (Diluted)	$0.61-7.6%	$0.66+32.0%	$0.50+28.2%	$0.39+116.7%	$0.18-59.1%	$0.44

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$79.7M+4.2%	$76.5M+2.8%	$74.4M+1.2%	$73.5M-1.0%	$74.2M+1.6%	$73.1M+2.2%	$71.6M-1.7%	$72.8M
Cost of Revenue	$28.9M+8.8%	$26.5M+0.5%	$26.4M+3.4%	$25.5M+1.5%	$25.1M+2.6%	$24.5M+3.1%	$23.7M-3.6%	$24.6M
Gross Profit	$50.9M+1.8%	$50.0M+4.0%	$48.0M+0.1%	$48.0M-2.3%	$49.1M+1.0%	$48.6M+1.7%	$47.8M-0.7%	$48.1M
R&D Expenses	$14.8M+21.9%	$12.1M+0.3%	$12.1M+0.2%	$12.0M-5.0%	$12.7M+4.8%	$12.1M+0.2%	$12.1M+0.4%	$12.0M
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	$2.4M-68.2%	$7.6M+28.6%	$5.9M+34.4%	$4.4M-6.6%	$4.7M-27.9%	$6.5M+47.3%	$4.4M-22.5%	$5.7M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$316K-85.4%	$2.2M+46.5%	$1.5M+61.4%	$916K+54.2%	$594K-66.1%	$1.8M+54.9%	$1.1M-14.0%	$1.3M
Net Income	$2.5M-58.3%	$6.1M+12.9%	$5.4M+24.4%	$4.3M-11.4%	$4.9M-14.6%	$5.7M+37.4%	$4.2M-20.3%	$5.2M
EPS (Diluted)	N/A	$0.20+11.1%	$0.18+28.6%	$0.14	N/A	$0.19+35.7%	$0.14-17.6%	$0.17

HSTM Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$520.4M+1.9%	$510.8M+2.2%	$499.9M+0.4%	$497.7M+2.3%	$486.8M-2.7%	$500.3M
Current Assets	$119.7M-21.9%	$153.1M+17.6%	$130.2M+13.8%	$114.4M+7.0%	$106.8M-6.9%	$114.7M
Cash & Equivalents	$36.2M-39.2%	$59.5M+47.4%	$40.3M-12.4%	$46.0M-1.9%	$46.9M+28.3%	$36.6M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$32.2M+6.5%	$30.2M-12.1%	$34.3M-6.5%	$36.7M+21.2%	$30.3M-25.6%	$40.7M
Goodwill	$217.5M+13.8%	$191.2M-0.1%	$191.4M-0.5%	$192.4M+5.4%	$182.5M+2.3%	$178.4M
Total Liabilities	$166.4M+9.9%	$151.4M-4.9%	$159.2M-2.7%	$163.7M+10.8%	$147.7M-11.1%	$166.3M
Current Liabilities	$124.1M+7.3%	$115.7M-2.3%	$118.4M+1.0%	$117.2M+16.8%	$100.3M-16.0%	$119.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$354.0M-1.5%	$359.4M+5.5%	$340.8M+2.0%	$334.1M-1.5%	$339.0M+1.5%	$334.1M
Retained Earnings	$123.6M+13.4%	$109.0M+18.0%	$92.4M+15.2%	$80.2M+17.7%	$68.1M+9.4%	$62.3M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$520.4M+4.1%	$499.9M0.0%	$500.1M-4.6%	$524.0M+2.6%	$510.8M+1.6%	$502.8M+0.7%	$499.6M-2.4%	$511.6M
Current Assets	$119.7M-18.9%	$147.6M+2.2%	$144.4M-14.9%	$169.7M+10.8%	$153.1M+5.1%	$145.6M+4.7%	$139.1M-5.6%	$147.4M
Cash & Equivalents	$36.2M-32.5%	$53.5M+2.8%	$52.1M-32.6%	$77.3M+30.0%	$59.5M+3.4%	$57.5M+24.6%	$46.1M-12.0%	$52.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$32.2M+16.2%	$27.7M+2.8%	$26.9M-12.7%	$30.8M+2.2%	$30.2M+14.7%	$26.3M-17.2%	$31.8M-19.8%	$39.6M
Goodwill	$217.5M+13.5%	$191.6M-0.1%	$191.8M+0.3%	$191.2M0.0%	$191.2M0.0%	$191.1M+0.1%	$191.0M-0.1%	$191.1M
Total Liabilities	$166.4M+10.4%	$150.7M+0.8%	$149.6M-7.2%	$161.2M+6.5%	$151.4M+2.8%	$147.3M-2.0%	$150.3M-9.8%	$166.8M
Current Liabilities	$124.1M+10.4%	$112.5M-2.5%	$115.4M-8.3%	$125.9M+8.8%	$115.7M+4.6%	$110.6M-1.2%	$111.9M-11.3%	$126.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$354.0M+1.4%	$349.2M-0.4%	$350.6M-3.4%	$362.8M+1.0%	$359.4M+1.1%	$355.5M+1.8%	$349.2M+1.3%	$344.9M
Retained Earnings	$123.6M+1.3%	$122.0M+4.4%	$116.8M+4.0%	$112.4M+3.1%	$109.0M+3.8%	$104.9M+4.9%	$100.1M+3.4%	$96.7M

HSTM Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$63.3M+9.8%	$57.7M-9.9%	$64.0M+25.0%	$51.2M+20.8%	$42.4M+18.1%	$35.9M
Capital Expenditures	$3.7M+163.0%	$1.4M-36.3%	$2.2M+24.4%	$1.8M-48.3%	$3.4M+71.9%	$2.0M
Free Cash Flow	$59.6M+6.0%	$56.3M-8.9%	$61.8M+25.0%	$49.4M+26.8%	$39.0M+15.0%	$33.9M
Investing Cash Flow	-$50.4M-48.2%	-$34.0M+40.0%	-$56.6M-99.4%	-$28.4M-10.4%	-$25.7M+76.7%	-$110.4M
Financing Cash Flow	-$36.3M-703.1%	-$4.5M+65.4%	-$13.0M+45.0%	-$23.7M-281.7%	-$6.2M+69.7%	-$20.5M
Dividends Paid	$3.7M+8.8%	$3.4M+9.7%	$3.1M	$0-100.0%	$19K-52.5%	$40K
Share Buybacks	$30.0M	$0-100.0%	$8.9M-61.4%	$23.1M+362.0%	$5.0M-75.0%	$20.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$13.2M-26.8%	$18.0M+258.9%	$5.0M-81.4%	$27.1M+142.6%	$11.2M-41.6%	$19.1M+196.2%	$6.5M-69.2%	$20.9M
Capital Expenditures	$204K+87.2%	$109K-95.3%	$2.3M+119.6%	$1.1M+419.7%	$203K-28.5%	$284K+65.1%	$172K-76.8%	$742K
Free Cash Flow	$13.0M-27.5%	$17.9M+562.3%	$2.7M-89.6%	$26.0M+137.5%	$11.0M-41.8%	$18.8M+199.8%	$6.3M-68.9%	$20.2M
Investing Cash Flow	-$23.3M-169.8%	-$8.6M+22.5%	-$11.2M-53.8%	-$7.2M+10.2%	-$8.1M-17.5%	-$6.9M+42.3%	-$11.9M-67.3%	-$7.1M
Financing Cash Flow	-$7.2M+8.7%	-$7.9M+58.4%	-$19.1M-847.5%	-$2.0M-94.9%	-$1.0M-12.0%	-$922K-7.6%	-$857K+49.7%	-$1.7M
Dividends Paid	$891K-3.0%	$919K-3.0%	$947K+0.4%	$943K+11.1%	$849K-0.2%	$851K0.0%	$851K+0.2%	$849K
Share Buybacks	$5.0M-27.4%	$6.9M	N/A	N/A	$0	$0	N/A	N/A

HSTM Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	64.7%-1.7pp	66.4%+0.5pp	66.0%+0.1pp	65.8%+1.3pp	64.5%+1.0pp	63.5%
Operating Margin	6.7%-0.6pp	7.3%+1.6pp	5.7%+1.1pp	4.7%+1.5pp	3.1%-3.3pp	6.5%
Net Margin	6.0%-0.8pp	6.9%+1.4pp	5.5%+0.9pp	4.5%+2.3pp	2.3%-3.5pp	5.8%
Return on Equity	5.2%-0.4pp	5.6%+1.1pp	4.5%+0.8pp	3.6%+1.9pp	1.7%-2.5pp	4.2%
Return on Assets	3.5%-0.4pp	3.9%+0.9pp	3.0%+0.6pp	2.4%+1.2pp	1.2%-1.6pp	2.8%
Current Ratio	0.96-0.4	1.32+0.2	1.10+0.1	0.98-0.1	1.06+0.1	0.96
Debt-to-Equity	0.47+0.0	0.42-0.0	0.47-0.0	0.49+0.1	0.44-0.1	0.50
FCF Margin	19.6%+0.3pp	19.3%-2.8pp	22.1%+3.6pp	18.5%+3.3pp	15.2%+1.3pp	13.8%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	63.8%-1.5pp	65.3%+0.8pp	64.6%-0.8pp	65.3%-0.8pp	66.2%-0.4pp	66.5%-0.3pp	66.8%+0.7pp	66.2%
Operating Margin	3.0%-6.9pp	9.9%+2.0pp	7.9%+2.0pp	6.0%-0.4pp	6.3%-2.6pp	8.9%+2.7pp	6.2%-1.7pp	7.8%
Net Margin	3.2%-4.8pp	8.0%+0.7pp	7.2%+1.3pp	5.9%-0.7pp	6.6%-1.2pp	7.8%+2.0pp	5.8%-1.4pp	7.2%
Return on Equity	0.7%-1.0pp	1.7%+0.2pp	1.5%+0.3pp	1.2%-0.2pp	1.4%-0.3pp	1.6%+0.4pp	1.2%-0.3pp	1.5%
Return on Assets	0.5%-0.7pp	1.2%+0.1pp	1.1%+0.3pp	0.8%-0.1pp	1.0%-0.2pp	1.1%+0.3pp	0.8%-0.2pp	1.0%
Current Ratio	0.96-0.3	1.31+0.1	1.25-0.1	1.35+0.0	1.320.0	1.32+0.1	1.24+0.1	1.17
Debt-to-Equity	0.47+0.0	0.430.0	0.43-0.0	0.44+0.0	0.420.0	0.41-0.0	0.43-0.1	0.48
FCF Margin	16.3%-7.1pp	23.4%+19.8pp	3.6%-31.8pp	35.4%+20.7pp	14.8%-11.0pp	25.8%+17.0pp	8.8%-19.0pp	27.8%

Note: The current ratio is below 1.0 (0.96), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Evolent Health Inc EVH

$254.5M

Weave Communications Inc WEAV

$363.4M

Performant Finl Corp PHLT

$623.4M

Omnicell Com OMCL

$1.5B

Phreesia PHR

$508.4M

Frequently Asked Questions

What is Healthstream's annual revenue?

Healthstream (HSTM) reported $304.1M in total revenue for fiscal year 2025. This represents a 4.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthstream's revenue growing?

Healthstream (HSTM) revenue grew by 4.3% year-over-year, from $291.6M to $304.1M in fiscal year 2025.

Is Healthstream profitable?

Yes, Healthstream (HSTM) reported a net income of $18.3M in fiscal year 2025, with a net profit margin of 6.0%.

What is Healthstream's EBITDA?

Healthstream (HSTM) had EBITDA of $63.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Healthstream's gross margin?

Healthstream (HSTM) had a gross margin of 64.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Healthstream's operating margin?

Healthstream (HSTM) had an operating margin of 6.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Healthstream's net profit margin?

Healthstream (HSTM) had a net profit margin of 6.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Healthstream pay dividends?

Yes, Healthstream (HSTM) paid $0.12 per share in dividends during fiscal year 2025.

What is Healthstream's return on equity (ROE)?

Healthstream (HSTM) has a return on equity of 5.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Healthstream's free cash flow?

Healthstream (HSTM) generated $59.6M in free cash flow during fiscal year 2025. This represents a 6.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Healthstream's operating cash flow?

Healthstream (HSTM) generated $63.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Healthstream's total assets?

Healthstream (HSTM) had $520.4M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Healthstream's capital expenditures?

Healthstream (HSTM) invested $3.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Healthstream spend on research and development?

Healthstream (HSTM) invested $51.0M in research and development during fiscal year 2025.

Does Healthstream buy back shares?

Yes, Healthstream (HSTM) spent $30.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Healthstream have outstanding?

Healthstream (HSTM) had 30M shares outstanding as of fiscal year 2025.

What is Healthstream's current ratio?

Healthstream (HSTM) had a current ratio of 0.96 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Healthstream's debt-to-equity ratio?

Healthstream (HSTM) had a debt-to-equity ratio of 0.47 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Healthstream's return on assets (ROA)?

Healthstream (HSTM) had a return on assets of 3.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Healthstream's Altman Z-Score?

Healthstream (HSTM) has an Altman Z-Score of 3.19, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Healthstream's Piotroski F-Score?

Healthstream (HSTM) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthstream's earnings high quality?

Healthstream (HSTM) has an earnings quality ratio of 3.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Healthstream?

Healthstream (HSTM) scores 47 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.